Goje O, Azie NE, Angulo DA, Sobel R, et al. A phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2025;233:617.
PMID: 40752754